Dan Lu

Wuhan University — China

Medicine · Health Sciences

29h-index2.7kcitations68works22.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(31), HER2/EGFR in Cancer Research(25), Cancer Treatment and Pharmacology(8), Glycosylation and Glycoproteins Research(7), CAR-T cell therapy research(7)

Publications68 total

Uncovering the mechanistic basis of <i>Rheum palmatum</i> L. (rhubarb) in the treatment of chronic kidney disease: an integrative approach using network pharmacology, molecular docking, and experimental validation
Pharmaceutical Biology·2025· 2 citedOpen Access
Impact of cropland use transformation on ecosystem carbon sinks in a typical agroforestry mixed region: An analysis from explicit and implicit perspectives
Environmental Impact Assessment Review·2025· 8 cited
The carbon emission reduction benefits of the transformation of the intensive use of cultivated land in China
Journal of Environmental Management·2024· 11 citedOpen Access
Patterns and drivers of terrace abandonment in China: Monitoring based on multi-source remote sensing data
Land Use Policy·2024· 18 cited
Understanding the impact of cultivated land-use changes on China's grain production potential and policy implications: A perspective of non-agriculturalization, non-grainization, and marginalization
Journal of Cleaner Production·2024· 73 cited
Evaluation of the efficiency and drivers of complemented cropland in Southwest China over the past 30 years from the perspective of cropland abandonment
Journal of Environmental Management·2023· 32 cited
Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017
Cell Reports·2022· 7 citedOpen Access
Effects of population spatial redistribution on vegetation greenness: A case study of Chongqing, China
Ecological Indicators·2022· 14 citedOpen Access
Identification of zinc‐chelating pumpkin seed ( <i>Cucurbita pepo L</i> .) peptides and in vitro transport of peptide–zinc chelates
Journal of Food Science·2022· 22 cited
512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors
Regular and Young Investigator Award Abstracts·2021· 1 citedOpen Access
Identification and Optimization of Production-Living-Ecological Space in an Ecological Foundation Area in the Upper Reaches of the Yangtze River: A Case Study of Jiangjin District of Chongqing, China
Land·2021· 51 citedOpen Access
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
Cell·2021· 153 citedOpen Access
Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in advanced solid tumors.
Journal of Clinical Oncology·2021· 6 cited
Spatiotemporal Changes of Ecosystem Service Value Determined by National Land Space Pattern Change: A Case Study of Fengdu County in The Three Gorges Reservoir Area, China
International Journal of Environmental Research and Public Health·2021· 16 citedOpen Access
Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?
Clinical Pharmacology & Therapeutics·2021· 63 citedOpen Access
Effect of Enzymatic Hydrolysis on the Zinc Binding Capacity and in vitro Gastrointestinal Stability of Peptides Derived From Pumpkin (Cucurbita pepo L.) Seeds
Frontiers in Nutrition·2021· 38 citedOpen Access
Effect of Roasting on the Antioxidant Activity, Phenolic Composition, and Nutritional Quality of Pumpkin (Cucurbita pepo L.) Seeds
Frontiers in Nutrition·2021· 59 citedOpen Access
Flight hormones as therapeutic target for novel Coronavirus infectious disease.
PubMed·2021
<i>Multiplexed Engineered, Off-the-Shelf T Cells Carrying Three Tumor-Associated Antigen-Targeting Modalities: CAR + Pan-Tumor Targeting TCR + CD16 Fc Receptor</i>
Blood·2020· 1 cited
Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates
The Journal of Clinical Pharmacology·2020· 14 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Sandhya Girish(13), Chunze Li(9), Peter Böhlen(8), Zhenping Zhu(8), Larry Witte(7), Xenia Jimenez(7), Divya Samineni(7), Jin Y. Jin(6), Amita Joshi(5), Shang‐Chiung Chen(5), Qingyuan Yang(5), Haifan Zhang(4), Paul Balderes(4), Daniel J. Hicklin(4), Zhanpeng Wang(4), Kangchuan Su(4), Aiwen Lin(4), Matts Kågedal(4), Manish Gupta(3), Bei Wang(3)